MARY BUCKWALTER: Open Payments
NPI 1013682012 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 65 payments from 14 companies in 2025. Trend: 2023 $472 · 2024 $911 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $306 |
| Janssen Biotech, Inc. | 7 | $145 |
| Celltrion USA Inc. | 4 | $102 |
| Madrigal Pharmaceuticals | 4 | $99 |
| Ardelyx, Inc. | 5 | $91 |
| PFIZER INC. | 4 | $63 |
| Ipsen Biopharmaceuticals, Inc | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
Products named: TREMFYA, RINVOQ, VEGZELMA, REZDIFFRA, IBSRELA, CREON, LINZESS, IQIRVO.
Industry payments across LA — which companies pay providers there.
